News

Advance notice of subsidy round FMS knowledge gaps in the field of treatment COVID-19 (in Dutch)

Advance notice of subsidy round FMS knowledge gaps in the field of treatment COVID-19 (in Dutch)
Covid-19, Ecosystems, Funding
Member News, Funding news

At the beginning of March 2021, ZonMw will publish the new subsidy call for treatment at COVID-19. The purpose of this call is to answer knowledge gaps identified in the Knowledge Agenda COVID19 of the Federation of Medical Specialists (FMS) that relate to treatments. 

COVID-19 knowledge gaps relevant to this call are:

  1. What is the frequency and what are the consequences of myocardial damage with COVID-19 and which interventions can we use to prevent short and long term myocardial damage?
  2. What is a good algorithm for safely removing someone from isolation after COVID-19?
  3. Does chest CT or PET / CT add value to clinical parameters for selection (and timing) of the most effective therapy for COVID-19, and to what extent is it predictive of chronic lung damage?
  4. What is the association of frailty and biological aging processes with disease course, mortality and functional outcomes in the prevention and treatment of COVID-19 in the elderly?
  5. Is the Clinical Frailty Scale (CFS) also predictive of outcomes for patients aged 70 and older living at home with a COVID-19 infection?
  6. What is the natural course of anosmia (lack of sense of smell) in the context of COVID-19 and can this be favorably influenced with (local) corticosteroids?

COVID-19 program specific relevance criteria:

  • The research provides the urgently needed knowledge to answer the knowledge gap described in the COVID-19 Knowledge Agenda.
  • The research is of great importance because it could impact the treatment of COVID-19 patients during the pandemic and its aftermath; or contribute to better preparedness for a possible next pandemic.
  • The application must convincingly substantiate that research leads to implementable (interim) results in the short term (at least during the pandemic and also for the long term)
  • The Netherlands is in a unique position to do this, whether it concerns research in which we can add value from the Netherlands to that which has already been deployed internationally;
  • The research does not already take place elsewhere;
  • A competent research group is available to tackle this in the short term (feasibility), unless there are compelling reasons such as obtaining an METC statement. 

NEWS​

Related News

Singapore – Singapore Health Technologies Ecosystem is ECHAlliance Ecosystem of the Month – June

12 Jun 2024
This month we are featuring our Singapore - Singapore Health Technologies Ecosystem as our Ecosystem of the Month.

Continence Thematic Innovation Ecosystem

11 Jun 2024
In celebration of Continence Week, we are excited to announce a collaborative webinar with the WFIPP focusing on our Continence Thematic Innovation Ec...

Presenting Kuopio Health members: ThingLink Oy

10 Jun 2024
ThingLink Oy is a Finnish learning technology company with global operations that develops user-friendly, scalable tools for creating interactive and ...

Presenting Kuopio Health members: Smart Visionary Solutions Oy

10 Jun 2024
Smart Visionary Solutions brings digital solutions to learning.

Presenting Kuopio Health members: Novo Granules Oy

10 Jun 2024
Novo Granules provides new pharmaceutical manufacturing solutions. Novo Granules is a company focused on dry granulation. The company is registered in...

Kuopio Health ecosystem R&D actors in spotlight – UEF SIB Labs

10 Jun 2024
UEF SIB Labs Science – Innovation – Business operates as a part of the Department of Technical Physics at the Faculty of Science, Forestry and Technol...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *